Metraipolis › archive › dc_8b665be2089f

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia — Europe PMC PMID:41632472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41632472
DOI
10.1001/jamanetworkopen.2025.57536
License (as archived)
solo-consultazione
Archived
2026-11-06T07:24:46.221Z
SHA-256 of the archived text
1d9e298557ab1dfd189e48f87940ddf9baec1dfe04e4c3e6d5ad38caac3375ea
Stable URL of this page
https://metraipolis.com/documento/dc_8b665be2089f

How to cite

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia — Europe PMC PMID:41632472 — Europe PMC (en), https://europepmc.org/article/MED/41632472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b665be2089f (Metraipolis archive dc_8b665be2089f, sha256 1d9e298557ab1dfd189e48f87940ddf9baec1dfe04e4c3e6d5ad38caac3375ea)
BibTeX
@misc{dc8b665be2089f,
  title = {Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia — Europe PMC PMID:41632472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41632472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b665be2089f; sha256 1d9e298557ab1dfd189e48f87940ddf9baec1dfe04e4c3e6d5ad38caac3375ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632472. Agents can read the archived copy with the MCP tool read_document.